| D008297 |
Male |
|
Males |
|
| D009842 |
Oligopeptides |
Peptides composed of between two and twelve amino acids. |
Oligopeptide |
|
| D011725 |
Pyridines |
Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES. |
|
|
| D011760 |
Pyrrolidinones |
A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) |
Pyrrolidinone,Pyrrolidone,Pyrrolidones |
|
| D004359 |
Drug Therapy, Combination |
Therapy with two or more separate preparations given for a combined effect. |
Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug |
|
| D005260 |
Female |
|
Females |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000068898 |
Raltegravir Potassium |
A pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION. |
Isentress,MK 0518,MK-0518,MK0518,Raltegravir,0518, MK,Potassium, Raltegravir |
|
| D000069446 |
Atazanavir Sulfate |
An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS. |
3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester,Atazanavir,BMS 232632,BMS-232632,BMS-232632-05,BMS232632,CGP 73547,CGP 75136,CGP 75176,CGP 75355,CGP-73547,CGP-75136,CGP-75176,CGP-75355,CGP75136,CGP75176,CGP75355,Reyataz,232632, BMS,BMS 232632 05,BMS23263205,CGP73547 |
|
| D000328 |
Adult |
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. |
Adults |
|
-transparent.png){kind=logo}
